We also found statistical significance for low membranous (p = 0.025) and cytoplasmic (p = 0.010) HER3 expression in predicting breast cancer recurrence during the follow-up period (Table 7, Fig. 4). The gene discussed is ERBB3; the disease is breast cancer.